Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07528742 · ClinicalTrials.gov registry record · NA
Vagus Nerve Stimulation for Reaction Time
A NA study, sponsored by Youngstown State University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07528742: Recruiting NA study, sponsored by Youngstown State University.
NCT07528742 is a NA study that is actively recruiting participants, run by Youngstown State University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07528742, a NA study, is actively recruiting participants, sponsored by Youngstown State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Non-Invasive Vagus Nerve Stimulation will be provided to the participants using a transcutaneous electrical nerve stimulation (TENS) unit, a routine physical therapy intervention by the faculty researcher who is a licensed physical therapist. The electrodes will be clipped to ear over the vagus nerve distribution area. The parameters will be 30 Hz, 250 us, 5 minutes, at tolerance (no pain). Reaction time will test collected pre and post the stimulation using online reaction time testing platform.
Primary Outcome
Reaction time will test collected pre and post the stimulation using online platform. The subjects will press a key when setting a color change in the computer screen.
Interventions
- DEVICE vagus nerve stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-04-06 |
| Est. Completion | 2027-04-05 |
| Phase | NA |
What NCT07528742 shows while recruiting
NCT07528742 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which vagus nerve stimulation is the first listed.
NCT07528742 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07528742 about?
NCT07528742 is a clinical study titled "Vagus Nerve Stimulation for Reaction Time". Non-Invasive Vagus Nerve Stimulation will be provided to the participants using a transcutaneous electrical nerve stimulation (TENS) unit, a routine physical therapy intervention by the faculty researcher who is a licensed physical therapist. The electrodes will be clipped to ear over the vagus nerv...
What is the current status of trial NCT07528742?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-04-06. Estimated completion is 2027-04-05.
What interventions are being tested in trial NCT07528742?
The interventions under investigation include: vagus nerve stimulation (DEVICE).
Who is sponsoring clinical trial NCT07528742?
This trial is sponsored by Youngstown State University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07528742's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI